OLSALAZINE SODIUM IN THE TREATMENT OF ULCERATIVE-COLITIS AMONG PATIENTS INTOLERANT OF SULFASALAZINE - A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, DOSE-RANGING CLINICAL-TRIAL

被引：99
|
作者：
MEYERS, S
SACHAR, DB
PRESENT, DH
JANOWITZ, HD
机构：
来源：
GASTROENTEROLOGY | 1987年 / 93卷 / 06期
关键词：
D O I：
10.1016/0016-5085(87)90253-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1255 / 1262
页数：8
相关论文
共 50 条
  • [21] Rituximab in rheumatoid arthritis: A double-blind, placebo-controlled, dose-ranging trial.
    Emery, P
    Fleischmann, RM
    Filipowicz-Sosnowska, A
    Schechtman, J
    Ramos-Remus, C
    Gomez-Reino, JJ
    Hessey, EW
    Shaw, TM
    Li, NF
    Agarwal, S
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S709 - S709
  • [22] A DOUBLE BLINDED, PLACEBO CONTROLLED CLINICAL-STUDY OF AZODISALICYLATE SODIUM (OLSALAZINE) IN THE TREATMENT OF ULCERATIVE-COLITIS
    ZINBERG, J
    MOLINAS, S
    DAS, KM
    GASTROENTEROLOGY, 1987, 92 (05) : 1711 - 1711
  • [23] A double-blind, dose-ranging, placebo-controlled trial of L-arginine for PAD
    Oka, RK
    Szuba, A
    Giacomini, JC
    Kapoor, O
    Soltani, A
    Bene, G
    Cooke, JP
    CIRCULATION, 2002, 106 (19) : 741 - 741
  • [24] RELAPSE-PREVENTING EFFECT AND SAFETY OF SULFASALAZINE AND OLSALAZINE IN PATIENTS WITH ULCERATIVE-COLITIS IN REMISSION - A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED MULTICENTER STUDY
    RIJK, MCM
    VANLIER, HJJ
    VANTONGEREN, JHM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1992, 87 (04) : 438 - 442
  • [25] Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial
    Sajjad Moradi
    Reza Bagheri
    Parsa Amirian
    Mahsa Zarpoosh
    Neda Cheraghloo
    Alexei Wong
    Mehdi Zobeiri
    Mohammad Hassan Entezari
    BMC Complementary Medicine and Therapies, 24
  • [26] Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial
    Moradi, Sajjad
    Bagheri, Reza
    Amirian, Parsa
    Zarpoosh, Mahsa
    Cheraghloo, Neda
    Wong, Alexei
    Zobeiri, Mehdi
    Entezari, Mohammad Hassan
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2024, 24 (01)
  • [27] A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum
    Hale, BR
    Owusu-Agyei, S
    Fryauff, DJ
    Koram, KA
    Adjuik, M
    Oduro, AR
    Prescott, WR
    Baird, JK
    Nkrumah, F
    Ritchie, TL
    Franke, ED
    Binka, FN
    Horton, J
    Hoffman, SL
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) : 541 - 549
  • [28] DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY OF ADENOSINE IN PATIENTS WITH SUPRAVENTRICULAR TACHYCARDIA
    CARUSO, AC
    MILES, WM
    KLEIN, LS
    ZIPES, DP
    CLINICAL RESEARCH, 1989, 37 (04): : A874 - A874
  • [29] PREDICTING THE OUTCOME OF CORTICOID THERAPY FOR ACUTE ULCERATIVE-COLITIS - RESULTS OF A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL
    MEYERS, S
    LERER, PK
    FEUER, EJ
    JOHNSON, JW
    JANOWITZ, HD
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1987, 9 (01) : 50 - 54
  • [30] BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
    Marcus, Ronald
    Goadsby, Peter J.
    Dodick, David
    Stock, David
    Manos, George
    Fischer, Tanya Z.
    CEPHALALGIA, 2014, 34 (02) : 114 - 125
12345